Clearside Biomedical, Inc. (CLSDQ) › Operating IncomeClearside Biomedical, Inc. (CLSDQ) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$9.82M2015: -$17.32M2016: -$25.20M2017: -$58.41M2018: -$82.94M2019: -$30.30M2020: -$17.93M2021: -$627.0K2022: -$30.28M2023: -$24.84M2024: -$28.88M-$28.88M2014Operating Income (USD)2024Fiscal YearOperating IncomeChange YoY2024-$28.88M-16.3%2023-$24.84M+17.9%2022-$30.28M-4728.9%2021-$627.0K+96.5%2020-$17.93M+40.8%2019-$30.30M+63.5%2018-$82.94M-42.0%2017-$58.41M-131.8%2016-$25.20M-45.5%2015-$17.32M-76.3%2014-$9.82M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share